• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

煅烧温度对布洛芬从羟基磷灰石粉末中释放行为的影响。

Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders.

作者信息

Melville Amanda J, Rodríguez-Lorenzo Luis M, Forsythe John S

机构信息

Department of Materials Engineering, Division of Biological Engineering, Monash University, Melbourne, Australia.

出版信息

J Mater Sci Mater Med. 2008 Mar;19(3):1187-95. doi: 10.1007/s10856-007-3185-4. Epub 2007 Aug 15.

DOI:10.1007/s10856-007-3185-4
PMID:17701302
Abstract

The effects of heat treatment time and temperature on the delivery behaviour of Ibuprofen from hydroxyapatite particles were investigated in this study. The drug release was seen to follow Fickian diffusion for the initial period of release for all heat treatment conditions. The gradient of Fickian release increased with (1) increasing crystallite size, attributed to the decreasing amount of boundary area, and (2) with decreasing surface area, due to the reduction in porosity and hence tortuosity within the apatite particles. This study has shown that altering the heat treatment conditions used to calcine hydroxyapatite may alter its drug delivery abilities, whereby calcination temperature was noted to influence the drug release behaviour to a greater extent than calcination time.

摘要

本研究考察了热处理时间和温度对布洛芬从羟基磷灰石颗粒中释放行为的影响。在所有热处理条件下,药物释放初期均符合菲克扩散。菲克释放的梯度随着以下因素增加:(1)晶粒尺寸增大,这归因于边界面积的减少;(2)表面积减小,这是由于磷灰石颗粒内孔隙率降低以及曲折度减小所致。本研究表明,改变用于煅烧羟基磷灰石的热处理条件可能会改变其药物递送能力,其中煅烧温度对药物释放行为的影响程度大于煅烧时间。

相似文献

1
Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders.煅烧温度对布洛芬从羟基磷灰石粉末中释放行为的影响。
J Mater Sci Mater Med. 2008 Mar;19(3):1187-95. doi: 10.1007/s10856-007-3185-4. Epub 2007 Aug 15.
2
Synthesis of hydroxyapatite crystals using carboxymethyl inulin for use as a delivery of ibuprofen.使用羧甲基菊粉合成羟基磷灰石晶体以用作布洛芬的递送载体。
Mater Sci Eng C Mater Biol Appl. 2013 Jan 1;33(1):482-9. doi: 10.1016/j.msec.2012.09.018. Epub 2012 Sep 29.
3
Synthesis and characterization of MCM-48/hydroxyapatite composites for drug delivery: Ibuprofen incorporation, location and release studies.MCM-48/羟基磷灰石复合材料的合成与表征及其药物传递性能:布洛芬的掺入、定位和释放研究。
Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:734-742. doi: 10.1016/j.msec.2018.06.028. Epub 2018 Jun 15.
4
Graphene oxide and creatine phosphate disodium dual template-directed synthesis of GO/hydroxyapatite and its application in drug delivery.氧化石墨烯和磷酸肌酸钠二钠盐双模板导向合成 GO/羟基磷灰石及其在药物传递中的应用。
Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:709-715. doi: 10.1016/j.msec.2016.11.083. Epub 2016 Nov 24.
5
In situ microemulsion synthesis of hydroxyapatite-MgFe2O4 nanocomposite as a magnetic drug delivery system.原位微乳液法合成羟基磷灰石 - 镁铁氧体纳米复合材料作为磁性药物递送系统
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:774-779. doi: 10.1016/j.msec.2016.07.028. Epub 2016 Jul 14.
6
Physico-chemical characterization and biological response of Labeo rohita-derived hydroxyapatite scaffold.源自露斯塔野鲮的羟基磷灰石支架的物理化学表征及生物学反应
Bioprocess Biosyst Eng. 2014 Jul;37(7):1233-40. doi: 10.1007/s00449-013-1095-z. Epub 2013 Nov 28.
7
Agarose encapsulated mesoporous carbonated hydroxyapatite nanocomposites powder for drug delivery.用于药物递送的琼脂糖包裹介孔碳酸羟基磷灰石纳米复合材料粉末
J Photochem Photobiol B. 2017 Jan;166:220-231. doi: 10.1016/j.jphotobiol.2016.12.005. Epub 2016 Dec 21.
8
Effect of powder calcination on the sintering of hydroxyapatite.粉末煅烧对羟基磷灰石烧结的影响。
Med J Malaysia. 2008 Jul;63 Suppl A:87-8.
9
Fabrication of novel Si-doped hydroxyapatite/gelatine scaffolds by rapid prototyping for drug delivery and bone regeneration.通过快速成型制备用于药物递送和骨再生的新型硅掺杂羟基磷灰石/明胶支架。
Acta Biomater. 2015 Mar;15:200-9. doi: 10.1016/j.actbio.2014.12.021. Epub 2015 Jan 3.
10
Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite.溶胶-凝胶法合成多功能、具有分级孔隙结构的二氧化硅/磷灰石复合材料。
Biomaterials. 2005 Dec;26(34):6827-35. doi: 10.1016/j.biomaterials.2005.05.002.

引用本文的文献

1
Emerging nano-scale delivery systems for the treatment of osteoporosis.用于治疗骨质疏松症的新兴纳米级递送系统。
Biomater Res. 2023 Jul 13;27(1):68. doi: 10.1186/s40824-023-00413-7.
2
The Role of the Sol-Gel Synthesis Process in the Biomedical Field and Its Use to Enhance the Performance of Bioabsorbable Magnesium Implants.溶胶-凝胶合成过程在生物医学领域的作用及其用于提高可生物吸收镁植入物的性能
Gels. 2022 Jul 7;8(7):426. doi: 10.3390/gels8070426.
3
Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders.骨靶向药物递送给骨质疏松症和罕见骨骼疾病带来的启示

本文引用的文献

1
Control of bisphosphonate release using hydroxyapatite granules.使用羟基磷灰石颗粒控制双膦酸盐释放
J Biomed Mater Res B Appl Biomater. 2006 Aug;78(2):215-21. doi: 10.1002/jbm.b.30446.
2
Development of porous spherical hydroxyapatite granules: application towards protein delivery.
J Mater Sci Mater Med. 1999 Jul;10(7):383-8. doi: 10.1023/a:1008918412198.
3
Porous ceramic bodies for drug delivery.
J Mater Sci Mater Med. 2000 Dec;11(12):763-71. doi: 10.1023/a:1008988127294.
4
Curr Osteoporos Rep. 2020 Oct;18(5):515-525. doi: 10.1007/s11914-020-00620-4.
4
Calcium Phosphate Nanoparticles for Therapeutic Applications in Bone Regeneration.用于骨再生治疗应用的磷酸钙纳米颗粒
Nanomaterials (Basel). 2019 Nov 6;9(11):1570. doi: 10.3390/nano9111570.
5
Mechanism of formation governs the mechanism of release of antibiotics from calcium phosphate nanopowders and cements in a drug-dependent manner.形成机制以药物依赖的方式控制了抗生素从磷酸钙纳米粉末和水泥中的释放机制。
J Mater Chem B. 2019 Jul 7;7(25):3982-3992. doi: 10.1039/c9tb00444k. Epub 2019 May 23.
6
Drug-Loaded Biomimetic Ceramics for Tissue Engineering.用于组织工程的载药仿生陶瓷
Pharmaceutics. 2018 Dec 13;10(4):272. doi: 10.3390/pharmaceutics10040272.
7
Influence of ibuprofen addition on the properties of a bioactive bone cement.布洛芬添加对生物活性骨水泥性能的影响。
J Mater Sci Mater Med. 2013 Aug;24(8):2067-76. doi: 10.1007/s10856-013-4958-6. Epub 2013 May 16.
8
Nanocrystalline hydroxyapatite and zinc-doped hydroxyapatite as carrier material for controlled delivery of ciprofloxacin.纳米晶羟基磷灰石和锌掺杂羟基磷灰石作为环丙沙星控释载体材料
3 Biotech. 2011 Oct;1(3):173-186. doi: 10.1007/s13205-011-0021-9. Epub 2011 Aug 24.
9
Porous bioactive glass scaffolds for local drug delivery in osteomyelitis: development and in vitro characterization.多孔生物活性玻璃支架用于骨髓炎的局部药物递送:开发和体外表征。
AAPS PharmSciTech. 2010 Dec;11(4):1675-83. doi: 10.1208/s12249-010-9550-5. Epub 2010 Nov 24.
10
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.骨组织工程治疗学:三维支架中的药物控释。
J R Soc Interface. 2010 Feb 6;7(43):209-27. doi: 10.1098/rsif.2009.0379. Epub 2009 Oct 28.
Biodegradable drug delivery system for the treatment of bone infection and repair.用于治疗骨感染和修复的可生物降解药物递送系统。
J Mater Sci Mater Med. 1999 Oct-Nov;10(10/11):653-8. doi: 10.1023/a:1008995926566.
5
Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.用于关节腔内给药的可生物降解的载布洛芬聚乳酸-羟基乙酸共聚物微球。添加Labrafil对体外释放的影响。
Int J Pharm. 2004 Jul 26;279(1-2):33-41. doi: 10.1016/j.ijpharm.2004.04.003.
6
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
7
Bioactive glass-polymer materials for controlled release of ibuprofen.
Biomaterials. 2003 Oct;24(22):4037-43. doi: 10.1016/s0142-9612(03)00279-5.
8
A method to fabricate porous spherical hydroxyapatite granules intended for time-controlled drug release.一种用于制备用于定时控释药物的多孔球形羟基磷灰石颗粒的方法。
Biomaterials. 2002 Aug;23(16):3449-54. doi: 10.1016/s0142-9612(02)00049-2.
9
Nucleation of biomimetic Ca-P coatings on ti6A14V from a SBF x 5 solution: influence of magnesium.在模拟体液(SBF)×5溶液中于Ti6Al4V上仿生钙磷涂层的成核:镁的影响
Biomaterials. 2002 May;23(10):2211-20. doi: 10.1016/s0142-9612(01)00354-4.
10
A fourier transform infrared spectroscopic and solid-state NMR study of bone mineral in osteogenesis imperfecta.
J Bone Miner Metab. 2000;18(5):291-6. doi: 10.1007/pl00010645.